The Discounted Cash Flow (DCF) valuation of Biogen Inc (BIIB) is 198.64 USD. With the latest stock price at 130.67 USD, the upside of Biogen Inc based on DCF is 52.0%.
Based on the latest price of 130.67 USD and our DCF valuation, Biogen Inc (BIIB) is a buy. buying Biogen stocks now will result in a potential gain of 52.0%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.8% | 7.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 162.90 - 253.41 | 198.64 |
| Upside | 24.7% - 93.9% | 52.0% |